Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...

The FDA has rejected more than a million vaping products with flavors like “Jimmy the Juice Man Peachy Strawberry” and ...

Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...

The University of Kentucky's Center for Clinical and Translational Science brought together around 1,000 clinicians, ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

The Supreme Court sided with a former commercial truck driver Wednesday who was fired after failing a drug test he said was ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

With growing bipartisan support, there’s an opportunity to tackle these issues head-on, and leaders in the healthcare space ...

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...

The pharmaceutical company lowers costs of medications for everyday consumers—but Trump’s tariffs might make that more ...